Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia)
Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia) is rated under 38 CFR 38 CFR § 4.117, Diagnostic Code 7719, from 30% to 100% based on the frequency and functional severity of symptoms. The maximum 100% rating requires: Requiring peripheral blood or bone marrow stem cell transplant, or continuous myelosuppressive or immunosuppressive therapy treatment. Most claims establish the 30% or 60% rating before reaching the top tier.
Rating schedule — DC 7719 at a glance
- Minimum rating
- 30%
- Maximum rating
- 100%
- Rating tiers
- 3
- CFR section
- 38 CFR § 4.117
- Body system
- Hematologic & Lymphatic System
- Secondary conditions
- 0
Lowest schedular rating available
Full schedular disability
30%, 60%, 100%
Part 4 rating schedule
None mapped
What are the VA rating criteria for Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia)?
In apparent remission on continuous molecularly targeted therapy with tyrosine kinase inhibitors
Requiring intermittent myelosuppressive therapy, or molecularly targeted therapy with tyrosine kinase inhibitors, or interferon treatment when not in apparent remission
Requiring peripheral blood or bone marrow stem cell transplant, or continuous myelosuppressive or immunosuppressive therapy treatment
“Requiring intermittent myelosuppressive therapy, or molecularly targeted therapy with tyrosine kinase inhibitors, or interferon treatment when not in apparent remission”
Common Questions About Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia) VA Ratings
What is the VA rating range for Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia)?
The VA rates Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia) under Diagnostic Code 7719 at 30%, 60%, 100%. The minimum 30% rating requires: In apparent remission on continuous molecularly targeted therapy with tyrosine kinase inhibitors. The maximum 100% rating requires: Requiring peripheral blood or bone marrow stem cell transplant, or continuous myelosuppressive or immunosuppressive therapy treatment.
Which 38 CFR diagnostic code does the VA use for Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia)?
The VA rates Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia) under Diagnostic Code (DC) 7719, governed by 38 CFR 38 CFR § 4.117. The diagnostic code establishes the specific rating tiers and severity criteria the VA examiner applies.
What is the difference between a 30% and a 100% rating for Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia)?
A 30% rating requires: In apparent remission on continuous molecularly targeted therapy with tyrosine kinase inhibitors. A 100% rating requires: Requiring peripheral blood or bone marrow stem cell transplant, or continuous myelosuppressive or immunosuppressive therapy treatment. The difference typically reflects the frequency, severity, or functional impact of the condition as documented in medical records and C&P examination findings.
Can Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia) qualify for TDIU (Total Disability Individual Unemployability)?
Veterans rated for Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia) may qualify for TDIU if the condition — alone or in combination with other service-connected disabilities — prevents substantially gainful employment. A single disability rated at 60% or higher (or multiple disabilities combining to 70%, with one at 40%) can support a TDIU claim under 38 CFR § 4.16.
What evidence do I need to establish service connection for Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia)?
Service connection for Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia) requires three elements: (1) a current diagnosis of the condition, (2) an in-service event, injury, or disease, and (3) a medical nexus linking the current diagnosis to that in-service occurrence. A nexus letter from a treating or independent medical examiner is the most reliable nexus evidence.
What is the C&P exam like for Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia)?
A Compensation & Pension (C&P) exam for Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia) uses a Disability Benefits Questionnaire (DBQ) specific to the body system involved. The examiner documents the frequency, severity, and functional impact of your symptoms. Bring all relevant treatment records and be prepared to describe your worst-day symptoms — the examiner rates your condition based on the full clinical picture, not a single visit.
Get a Personalized Rating Analysis
VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.
Discover Your Benefits